JP Morgan Chase’s MEDIROM Healthcare Technologies MRM Stock Holding History

JP Morgan Chase’s Portfolio MRM Stock Details MRM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-1,600	Closed	-$12K	–	6724
2022 Q1	$12K	Buy	+1,600	New	+$10.9K	﹤0.01%	6176

Other funds holding MRM

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

JP Morgan Chase's MRM Position: Q2 2022 in Review

JP Morgan Chase sold out of MEDIROM Healthcare Technologies (MRM) in Q2 2022, closing a stake of 1,600 shares — an estimated $12K sold.

JP Morgan Chase first reported a position in MRM in Q1 2022 and held it in 1 quarter. The position peaked at $12K in Q1 2022. 1 fund tracked by Wall St. Rank holds MRM as of Q2 2022.

JP Morgan Chase reported no remaining MEDIROM Healthcare Technologies position as of Q2 2022 after selling out during the quarter.
JP Morgan Chase sold 1,600 MEDIROM Healthcare Technologies shares in Q2 2022, an estimated $12K.
JP Morgan Chase first reported a position in MEDIROM Healthcare Technologies in Q1 2022 and held it in 1 quarter.
JP Morgan Chase's MEDIROM Healthcare Technologies position peaked at $12K in Q1 2022.
1 fund tracked by Wall St. Rank held MEDIROM Healthcare Technologies as of Q2 2022.

Based on JP Morgan Chase's 13F filing for Q2 2022, filed 11 Aug 2022.